Course Description: Despite advances in gender-affirming care and growing acceptance of gender diversity, transgender and nonbinary (TNB) people continue to experience barriers to inclusive care, such as stigma and social determinants of health. Join the Effi Barry Training Institute, led by HealthHIV, on Wednesday, August 14 from 1:00pm to 2:00pm EDT for a webinar that will familiarize Washington, DC providers with culturally-responsive and equitable healthcare for TNB patients. The faculty will review best practices for improved health outcomes among TNB people in order to reduce health disparities that affect the transgender population. Implementation of these practices will also contribute to higher retention in care at your organization.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Release Date: August 14, 2024
Expiration Date: August 14, 2025
UAN #: JA4008162-9999-24-398-L99-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss key healthcare opportunities where gender modality has an outsized influence on health
- Describe the experiences of transgender and nonbinary (TNB) patients and colleagues in the healthcare setting
- Implement at least one practical strategy to advance inclusion of transgender and nonbinary (TNB) patients and colleagues
Faculty
Diane Bruessow, MPAS, PA-C, DFAAPA (she/her)Assistant Professor Adjunct in the Department of General Internal Medicine and the Director of Justice, Equity, Diversity, and Inclusion in the PA Online program at Yale School of Medicine
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for1 contact hour(s) (0. 1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation
This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.